These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

888 related articles for article (PubMed ID: 18088267)

  • 1. Estimating the cost of epilepsy in Europe: a review with economic modeling.
    Pugliatti M; Beghi E; Forsgren L; Ekman M; Sobocki P
    Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the cost of MS in Europe: extrapolations from a multinational cost study.
    Sobocki P; Pugliatti M; Lauer K; Kobelt G
    Mult Scler; 2007 Sep; 13(8):1054-64. PubMed ID: 17623729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany.
    Hamer HM; Spottke A; Aletsee C; Knake S; Reis J; Strzelczyk A; Oertel WH; Rosenow F; Dodel R
    Epilepsia; 2006 Dec; 47(12):2165-72. PubMed ID: 17201718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
    Hong Z; Qu B; Wu XT; Yang TH; Zhang Q; Zhou D
    Epilepsia; 2009 Oct; 50(10):2192-8. PubMed ID: 19583782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economic impact of overactive bladder syndrome in six Western countries.
    Irwin DE; Mungapen L; Milsom I; Kopp Z; Reeves P; Kelleher C
    BJU Int; 2009 Jan; 103(2):202-9. PubMed ID: 19278532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost estimates of brain disorders in Belgium.
    Schoenen J; Gianni F; Schretlen L; Sobocki P
    Acta Neurol Belg; 2006 Dec; 106(4):208-14. PubMed ID: 17323838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current and future burden and cost of overactive bladder in five European countries.
    Reeves P; Irwin D; Kelleher C; Milsom I; Kopp Z; Calvert N; Lloyd A
    Eur Urol; 2006 Nov; 50(5):1050-7. PubMed ID: 16753252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost of obesity in Canada.
    Birmingham CL; Muller JL; Palepu A; Spinelli JJ; Anis AH
    CMAJ; 1999 Feb; 160(4):483-8. PubMed ID: 10081464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute coronary syndromes in Europe: 1-year costs and outcomes.
    Taylor MJ; Scuffham PA; McCollam PL; Newby DE
    Curr Med Res Opin; 2007 Mar; 23(3):495-503. PubMed ID: 17355731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct medical cost of children and adolescents epilepsy at a university setting in Croatia.
    Prpić I; Boban M; Skarpa-Prpić I; Jurjević A; Babić T; Fiket D
    Coll Antropol; 2009 Jun; 33(2):503-8. PubMed ID: 19662770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The worldwide societal costs of dementia: Estimates for 2009.
    Wimo A; Winblad B; Jönsson L
    Alzheimers Dement; 2010 Mar; 6(2):98-103. PubMed ID: 20298969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Socioeconomic costs of stroke in Korea: estimated from the Korea national health insurance claims database].
    Lim SJ; Kim HJ; Nam CM; Chang HS; Jang YH; Kim S; Kang HY
    J Prev Med Public Health; 2009 Jul; 42(4):251-60. PubMed ID: 19675402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The economic impact of dementia in Europe in 2008-cost estimates from the Eurocode project.
    Wimo A; Jönsson L; Gustavsson A; McDaid D; Ersek K; Georges J; Gulácsi L; Karpati K; Kenigsberg P; Valtonen H
    Int J Geriatr Psychiatry; 2011 Aug; 26(8):825-32. PubMed ID: 21744385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The burden of illness associated with renal cell carcinoma in the United States.
    Lang K; Danchenko N; Gondek K; Schwartz B; Thompson D
    Urol Oncol; 2007; 25(5):368-75. PubMed ID: 17826652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cost-of-illness of asthma in Denmark in the year 2000].
    Mossing R; Nielsen GD
    Ugeskr Laeger; 2003 Jun; 165(26):2646-9. PubMed ID: 12886546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of disorders of the brain in Denmark.
    Olesen J; Sobscki P; Truelsen T; Sestoft D; Jönsson B
    Nord J Psychiatry; 2008; 62(2):114-20. PubMed ID: 18569774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of first-line antiepileptic drug treatments in the developing world: a population-level analysis.
    Chisholm D;
    Epilepsia; 2005 May; 46(5):751-9. PubMed ID: 15857443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.